Kaveri Pohlman
Stock Analyst at Clear Street
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AVBP ArriVent BioPharma | Initiates Coverage On: Buy | 32 | 22.84 | 40.11% | 1 | Jun 25, 2025 | |
MGNX Macrogenics | Downgrades: Neutral | n/a | n/a | n/a | 4 | Aug 1, 2024 | |
GMAB Genmab | Maintains: Strong Buy | 46 47 | 20.52 | 129.04% | 3 | Jun 27, 2024 | |
CGEM Cullinan Oncology | Maintains: Strong Buy | 20 30 | 7.76 | 286.6% | 2 | Apr 17, 2024 | |
XNCR Xencor | Maintains: Buy | 56 38 | 8.16 | 365.69% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 5 | 1.95 | 156.41% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 62 | 23.22 | 167.01% | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 1.11 | 620.72% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 43.67 | -38.17% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 26 | n/a | n/a | 1 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 70 | 7.95 | 780.5% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 0.91 | 1218.68% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 8 | 2.27 | 252.42% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 125 | n/a | n/a | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Apr 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 100 | n/a | n/a | 1 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12320 4928 | 1.11 | 443863.96% | 2 | Feb 9, 2022 |